Guibao, Baby Boy .

HRN: 24-67-15  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2024
AMPICILLIN 1GM (VIAL)
03/11/2024
03/17/2024
IV
160
Q12
Potentially Septic Newborn: Thickly MSAF
Waiting Final Action 
03/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/11/2024
03/17/2024
IV
16mg
Q24
Potentially Septic Newborn: Thickly MSAF
Waiting Final Action 
03/11/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
03/11/2024
03/11/2024
EYE OINTMENT
3.5g
1x
Prophylaxis
Waiting Final Action 
03/13/2024
CEFOTAXIME 500MG (VIAL)
03/13/2024
03/19/2024
IVT
160mg
Q12
Psnb, Thickly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: